Individuals with obesity may also exhibit cardioprotection due to higher circulating estrogen (a potent vasodilator) from the conversion of androgens by aromatase in adipose tissue [29]. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.